Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Achaogen, Inc. stock logo
AKAOQ
Achaogen
$0.03
+0.8%
$0.02
$0.00
$0.05
$1.21M-0.81186,196 shs68,500 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.06
$0.07
$0.00
$0.12
$18.29M1.7796,756 shs138,416 shs
MusclePharm Co. stock logo
MSLP
MusclePharm
$0.00
$0.00
$0.00
$7K-0.0726,442 shsN/A
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
$5.50
$2.80
$0.52
$9.12
$2.16M0.549,053 shs4 shs
TRPX
Therapix Biosciences
$0.10
$0.23
$0.25
$4.69
$351KN/A1.59 million shs95,212 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Achaogen, Inc. stock logo
AKAOQ
Achaogen
0.00%0.00%0.00%0.00%0.00%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.00%-13.24%-10.61%-26.25%+84.38%
MusclePharm Co. stock logo
MSLP
MusclePharm
0.00%0.00%0.00%0.00%-53.85%
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
0.00%+29.41%+86.76%+146.64%+23.87%
TRPX
Therapix Biosciences
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Achaogen, Inc. stock logo
AKAOQ
Achaogen
N/AN/AN/AN/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/AN/AN/AN/AN/A
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Achaogen, Inc. stock logo
AKAOQ
Achaogen
N/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/A
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Achaogen, Inc. stock logo
AKAOQ
Achaogen
$8.73M0.14N/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$50K365.78N/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
$50.04M0.00N/AN/A($0.94) per share0.00
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Achaogen, Inc. stock logo
AKAOQ
Achaogen
-$186.51MN/A0.00N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-$370KN/A0.00N/A5.77%20.61%11.73%N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
-$12.87M-$0.58N/AN/AN/A-38.51%N/A-169.56%N/A
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
-$160KN/A0.00N/AN/AN/A-159.55%N/A
TRPX
Therapix Biosciences
-$4.79MN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Achaogen, Inc. stock logo
AKAOQ
Achaogen
N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/AN/A
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Achaogen, Inc. stock logo
AKAOQ
Achaogen
N/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.10
0.87
0.39
MusclePharm Co. stock logo
MSLP
MusclePharm
N/A
0.25
0.23
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/A
0.15
0.15
TRPX
Therapix Biosciences
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Achaogen, Inc. stock logo
AKAOQ
Achaogen
N/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
15.49%
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
N/A
TRPX
Therapix Biosciences
14.32%

Insider Ownership

CompanyInsider Ownership
Achaogen, Inc. stock logo
AKAOQ
Achaogen
7.80%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
24.90%
MusclePharm Co. stock logo
MSLP
MusclePharm
60.70%
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
18.40%
TRPX
Therapix Biosciences
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Achaogen, Inc. stock logo
AKAOQ
Achaogen
4248.21 millionN/ANot Optionable
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
8309.98 million232.80 millionNot Optionable
MusclePharm Co. stock logo
MSLP
MusclePharm
2733.39 million13.12 millionNot Optionable
Peak Pharmaceuticals, Inc. stock logo
PKPH
Peak Pharmaceuticals
1392,000320,000Not Optionable
TRPX
Therapix Biosciences
93.51 millionN/ANot Optionable

MSLP, TRPX, PKPH, ETST, and AKAOQ Headlines

SourceHeadline
Anixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, PredictionsAnixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 12 at 5:48 AM
Sagimet Biosciences Inc (SGMT)Sagimet Biosciences Inc (SGMT)
investing.com - August 23 at 7:29 AM
PBIO Pressure BioSciences, Inc.PBIO Pressure BioSciences, Inc.
seekingalpha.com - August 1 at 3:24 PM
Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017s IPOsCannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs
thestreet.com - January 19 at 7:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Achaogen logo

Achaogen

OTCMKTS:AKAOQ
Achaogen, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial agents for multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin for the treatment of serious bacterial infections due to MDR enterobacteriaceae comprising carbapenem-resistant enterobacteriaceae. It is also involved in the development of antibacterial candidate C-Scape, an orally-administered combination of clavulanate and ceftibuten, which targets serious bacterial infections due to expanded spectrum beta-lactamases producing enterobacteriaceae. The company has license and collaboration agreements with Thermo Fisher Scientific, Inc. to develop and commercialize an assay to support plazomicin; Crystal Biosciences, Inc. to discover monoclonal antibodies against multiple targets; Ionis Pharmaceuticals, Inc. for certain patents relating to aminoglycoside antibacterial compounds and related know-how to develop and commercialize certain novel aminoglycoside antibacterial compounds; and Hovione Limited manufacture the active pharmaceutical ingredient for plazomicin. The company was incorporated in 2002 and is based in South San Francisco, California. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on May 29, 2020.
Earth Science Tech logo

Earth Science Tech

OTCMKTS:ETST
Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
MusclePharm logo

MusclePharm

OTCMKTS:MSLP
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Peak Pharmaceuticals logo

Peak Pharmaceuticals

OTCMKTS:PKPH
Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Therapix Biosciences

NASDAQ:TRPX